Evaluation of apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study

HIGHLIGHTS

  • who: Khalid Al Sulaiman from the Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint University, POBox, Riyadh, Saudi Arabia have published the Article: Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study, in the Journal: (JOURNAL)
  • what: This study showed similar effectiveness and safety of apixaban use in both morbid obese and non-morbid obese patients with non-valvular AF.
  • how: The authors conducted this exploratory study to evaluate the efficacy and safety of using apixaban in AF patients who are morbidly obese . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?